Aberdeen Group’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.9M Buy
391,809
+126,940
+48% +$8.69M 0.03% 444
2025
Q4
$18.4M Sell
264,869
-322,000
-55% -$13.1M 0.03% 461
2025
Q3
$16.4M Buy
586,869
+185,245
+46% +$3.69M 0.03% 494
2025
Q2
$8.33M Buy
401,624
+152,725
+61% +$3.36M 0.01% 638
2025
Q1
$4.31M Buy
248,899
+77,511
+45% +$1.9M 0.01% 694
2024
Q4
$4.65M Sell
171,388
-45,695
-21% -$1.62M 0.01% 661
2024
Q3
$9.53M Buy
217,083
+123,789
+133% +$4.79M 0.02% 530
2024
Q2
$3.66M Buy
+93,294
New +$3.83M 0.01% 682

Other funds holding GPCR